Internal Medicine Doctors in Woburn, MA Accepting Medicare

21 Internal Medicine doctors found. Showing 1 - 20

Katherine Helen Michener, M.D. Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 23 Warren Ave, Suite 150, Woburn, MA 01801 Phone: 781-933-0710    Fax: 781-937-3947

Arthur S Kress, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 23 Warren Ave, Suite 100, Woburn, MA 01801 Phone: 781-933-1198    Fax: 781-933-9246

Anna Shifrin, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 200 Unicorn Park Dr Ste 402, Woburn, MA 01801 Phone: 603-943-5580

Karishma Patel, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 7 Alfred St Ste 370, Woburn, MA 01801 Phone: 781-528-6720

Najmuddin Patwa, M.D. Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 12 Alfred Street, Suite 120, Woburn, MA 01801 Phone: 781-756-4070    Fax: 781-756-4075

Malini Sharma, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 23 Warren Ave, Suite 100, Woburn, MA 01801 Phone: 781-933-1198    Fax: 781-933-9246

Emily G Lowry, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 2 Rehabilitation Way, Woburn, MA 01801 Phone: 781-935-5050

Peter Azar, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 23 Warren Ave, Suite 100, Woburn, MA 01801 Phone: 781-933-1198    Fax: 781-933-9246

Esmet A Hakim, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 2 Rehabilitation Way, Woburn, MA 01801 Phone: 781-935-5050

Pinky Jain, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 23 Warren Ave, Suite 100, Woburn, MA 01801 Phone: 781-933-1198

Salvador Albanese, M.D. Internal Medicine - Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 23 Warren Ave, Ste 100, Woburn, MA 01801 Phone: 781-933-1198    Fax: 781-933-9246

Dr. Shiva Gupta, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 7 Alfred St Ste 370, Woburn, MA 01801 Phone: 781-528-6720    Fax: 781-528-6720

Susan Auerbach-ferdman, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 18 Commerce Way, Woburn, MA 01801 Phone: 781-933-8060

Dr. Ghary Jed Gappelberg, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 23 Warren Ave, Woburn, MA 01801 Phone: 978-988-9255    Fax: 978-694-9675

Leonida Lucinda Rasenas, M.D. Internal Medicine - Nephrology Medicare: Medicare Enrolled Practice Location: 23 Warren Ave, Suite 150, Woburn, MA 01801 Phone: 781-933-0710    Fax: 781-937-3947

Dr. Michele A Crage, M.D. Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 23 Warren Ave, Suite 150, Woburn, MA 01801 Phone: 781-933-0710    Fax: 781-937-3947

Beverly L Bowker, M.D. Internal Medicine - Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 7 Alfred St, Woburn, MA 01801 Phone: 781-756-2301

Christina E Kwack-yuhan, M.D. Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: Woburn Nephrology Associates, P.c., 23 Warren Ave Suite 150, Woburn, MA 01801 Phone: 781-933-0710

Dr. Mithun S. Nallari, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 23 Warren Avenue, Suite #100, Woburn, MA 01801 Phone: 781-933-1198    Fax: 781-933-9246

Chitra Yang King, M.D. Internal Medicine - Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 7 Alfred Street, Baldwin Park Ii, Suite 230, Woburn, MA 01801 Phone: 781-756-2301    Fax: 781-756-7250

News Archive

Advaxis announces full exercise of over-allotment option granted to underwriters

Advaxis, Inc., a leader in developing the next generation of immunotherapies for cancer and infectious diseases, today announced the full exercise of the over-allotment option granted to the underwriters to purchase an additional 862,500 shares of its common stock and warrants to purchase an additional 431,250 shares (15% of the shares and warrants sold in this offering), at a public offering price of $4.00 per share and $0.001 per warrant, respectively, in connection with its previously announced underwritten public offering of 5,750,000 shares of common stock, and warrants to purchase up to an aggregate of 2,875,000 shares of common stock, bringing the total gross proceeds from the offering to approximately $26,500,000, before deducting underwriting discounts and commissions and other offering expenses payable by Advaxis, Inc.

Lung disease linked to the use of contaminated well water in a CPAP machine

Many people rely on continuous positive airway pressure (CPAP) machines as a safe and effective treatment for sleep apnea. But a new case report describes a rare complication—a lingering inflammatory disease of the lungs, apparently related to the use of contaminated well water in a CPAP machine. The report appears in the December Southern Medical Journal, official journal of the Southern Medical Association.

Taiwan aims to boost fertility rates

Targeting the issue of low birth rates, the Taiwanese government implemented the Mega Warmth Social Welfare Program (MWSWP) in 2006 after its fertility rates dipped lower than most industrial nations.

U.S. Department of Health & Human Services has announced progress toward expanding the nation's supply of vaccines for flu season

The Food and Drug Administration (FDA) has identified about 5 million doses of influenza vaccine from foreign manufacturers; HHS has been able to recoup an additional 300,000 doses of the injectable vaccine originally bought for federal employees and the military; and a major pneumonia vaccine manufacturer plans to triple its production.

Myrexis commences Azixa controlled two-arm Phase 2b clinical study in GBM

Myrexis, Inc., a biotechnology company focused on discovering, developing, and commercializing novel treatments for cancer, today announced it has initiated a controlled two-arm Phase 2b clinical study of Azixa (verubulin) as a front-line treatment for glioblastoma multiforme (GBM).

Read more Medical News

› Verified 3 days ago

• 1(current)
• 2